Nasilin, Abdul Siarip .

HRN: 27-51-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
CEFUROXIME 750MG (VIAL)
08/25/2025
08/31/2025
IVTT
140mg
Q8
Repiratory Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines